Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Latanoprost Ophthalmic Solution Manufacturing

Active

Federal

Response Deadline10/16/2026, 07:30:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract involves the manufacturing of Latanoprost Ophthalmic Solution to support prime contractors on pharmaceutical procurement projects for the Department of Veterans Affairs. The scope of work encompasses the entire production process, including chemical synthesis, formulation, and sterile filling into ocular medication containers. All operations must be conducted within cleanrooms using pharmaceutical-grade API and in strict adherence to current Good Manufacturing Practices. To ensure safety and standardization, the manufacturer must follow the American Academy of Ophthalmology’s uniform color-coding system for all labels and caps. The final deliverable consists of finished, labeled, and packaged solutions assigned a unique NDC number. This project is categorized under NAICS code 325412 and is managed through Nac Pharmaceuticals.

General Info

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL

Set-Aside

NONE

Documents

This scope was carved out of 36E79727R0039.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--Latanoprost Ophthalmic Solution (VA-27-00006027)

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedOct 2

subcontract

Response DeadlineOct 16

Submission deadline

Response Deadline

10/16/2026, 07:30:00 PM UTCin 14 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Manufactures Latanoprost Ophthalmic Solution for prime contractors on Department of Veterans Affairs pharmaceutical procurement projects. Performs chemical synthesis, formulation, and sterile filling into ocular medication containers using cleanrooms and pharmaceutical-grade API. Adheres to cGMP and the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. Delivers finished, labeled, and packaged solution with a unique NDC number.

Similar Contracts

Same NAICS industry code

6505--Latanoprost Ophthalmic Solution (VA-27-00006027)

Solicitation # 36E79727R0039

The Department of Veterans Affairs Enterprise Procurement Office is initiating an unrestricted procurement under solicitation 36E79727R0039 for Latanoprost Ophthalmic Solution. This acquisition aims to establish an uninterrupted source of supply for the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will be awarded to a single responsible offeror for a base period of one year with four pre-priced one-year option periods. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The procurement is issued in commercial item format per FAR Part 12 under NAICS code 325412 and is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. Strict labeling requirements are in place, requiring offerors to provide a unique NDC number and the exact drug name as it appears on the label. The contractor's label must be the sole label on the product, cannot be affixed over another label, and must allow VA labels to adhere securely on top. Additionally, vendors must comply with the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. The solicitation is expected to be issued around October 21, 2026, with a tentative closing date of November 4, 2026, though some metadata indicates a response deadline of October 16, 2026.

Nac Pharmaceuticals (36E797)

POSTED

about 16 hours ago

DEADLINE

Supply of Bismuth Subsalicylate Suspension

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Ibuprofen Oral Suspension, USP

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Occlusive Adhesive Dressing Supplier

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Albendazole Tablets, USPThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Albendazole Tablets, USP, for prime contractors supporting DLA Troop Support medical supply contracts. The requirement is for 168 bottles of tablets under NSN 6505-01-649-3422, which must meet all USP specifications and be delivered FOB Destination to Fort Bragg. The supplier must maintain FDA registration and ensure the product is packaged in bottles with a non-extendable 24-month shelf life, designated as Type I, Code M. This procurement falls under NAICS code 325412, with a response deadline set for October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Poison Ivy Skin Wash

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Multiple Electrolytes Injection, Type 1

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Loperamide Hydrochloride Capsules

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Fluconazole Tablets 150 MG

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Ceftriaxone Sodium in Dextrose InjectionThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Ceftriaxone Sodium in Dextrose Injection to prime contractors for DLA Troop Support medical supply contracts. The requirement is for five packages, each containing 24 plastic bags of 1 gram Ceftriaxone frozen and premixed in an iso-osmotic solution with 1.9 gram dextrose. To ensure product integrity, the contractor must utilize cold-chain storage and transport equipment to maintain a temperature of -20 degrees Celsius per USP standards, with packaging adhering to MIL-STD-2073-1E. The performance location for this contract is FPO 09566-4008, and the response deadline is October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Lactated Ringer's Injection, USP

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing (Pentobarbital Sodium)This subcontract involves the manufacture and supply of 20,000 units of pharmaceutical grade Pentobarbital Sodium (NSN 6509-01-485-6206) for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The scope of work encompasses the entire production lifecycle, including chemical synthesis, formulation, and rigorous quality control testing to ensure purity. All materials must be packaged in clean-room facilities using specialized pharmaceutical equipment in accordance with MIL-STD-2073-1E standards. Due to the nature of the substance, the performing entity must maintain active FDA and DEA registrations for handling controlled substances. The project falls under NAICS code 325412 and is designated for performance at APO 96368-5268. Interested parties should note the tight response window following the October 1, 2026, posting date.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

Pharmaceutical Distribution ServicesThis subcontract for Pharmaceutical Distribution Services involves providing specialized logistics support for prime contractors serving the Department of Veterans Affairs and Department of Defense Pharmaceutical Prime Vendor Programs. The scope of work includes managing cold chain transport and storage, coordinating shipments to CMOPs and TMOPs, and maintaining inventory levels to ensure an uninterrupted supply of medical products delivered to program hubs. The contractor must operate in strict compliance with the Drug Supply Chain Security Act and Good Distribution Practices. This opportunity is categorized under NAICS code 424210 and is associated with Nac Pharmaceuticals. Interested parties should note the response deadline of October 16, 2026.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 16 hours ago

DEADLINE

Pharmaceutical Labeling and Packaging ServicesThis subcontract for Pharmaceutical Labeling and Packaging Services supports prime contractors on Department of Veterans Affairs pharmaceutical projects. The scope of work involves the production and delivery of compliant packaging components, specifically focusing on labels featuring unique NDC numbers and bottle caps that adhere to the American Academy of Ophthalmology color-coding system. To ensure operational integrity, the provider utilizes medical-grade adhesives to securely affix VA labels over existing contractor labels. Managed under NAICS code 323111 for Nac Pharmaceuticals, the opportunity was posted on October 2, 2026, with a response deadline of October 16, 2026. The contract ensures that all specialized labeling and packaging materials meet the strict regulatory and safety requirements necessary for pharmaceutical distribution within the VA system.

Commercial Printing (except Screen and Books)

POSTED

about 16 hours ago

DEADLINE

6505--Prednisolone 1% Ophthalmic Solution

Solicitation # 36E79726R0037

The Department of Veterans Affairs, through the OPAL Enterprise Procurement Office, is soliciting offers for the procurement of Prednisolone Acetate 1% Ophthalmic Suspension. This unrestricted procurement is designated as a HUBZONE Small Business set-aside and aims to establish an uninterrupted source of supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract consists of a one-year base period with four pre-priced one-year option periods. Supplies will be distributed via the VA and DoD Pharmaceutical Prime Vendor Programs, with requirements for three package sizes: 5ml, 10ml, and 15ml bottles. Award will be made to a single responsible offeror for all line items based on the Lowest Price Technically Acceptable (LPTA) approach. To be considered technically acceptable, offerors must provide FDA-approved pharmaceuticals with unique 11-digit NDC numbers and demonstrate that manufacturing facilities are FDA cGMP acceptable. Strict packaging and labeling standards are required, including GS1-128 or HIBC linear bar codes and 2D data matrix bar codes per the Drug Supply Chain Security Act. Proposals must be submitted by October 14, 2026, and must include a signed SF-1449, a 0.5% cost recovery fee in the pricing, and a letter of commitment from the manufacturer if the offeror is not the producer.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Labeling and Packaging SupplierThis subcontract with Nac Pharmaceuticals for the Department of Veterans Affairs involves the supply of medical-grade pharmaceutical packaging for approximately 462,000 units. The scope of work includes providing 5 ML and 10 ML bottles designed for compatibility with 5.25 by 2 inch labels, specifically ensuring a 0.5 inch space for barcodes and lot numbers. The supplier is responsible for providing adhesive label stock that supports secure VA over-labeling without the need for additional over-labeling. This procurement falls under NAICS code 326199 and was posted on September 25, 2026, with a response deadline of October 15, 2026.

All Other Plastics Product Manufacturing

POSTED

DEADLINE

Prednisolone Acetate 1% Ophthalmic Suspension ManufacturerNac Pharmaceuticals is seeking a subcontractor to manufacture and supply Prednisolone Acetate 1% Ophthalmic Suspension for Department of Veterans Affairs pharmaceutical supply contracts. The selected provider will be responsible for the formulation, production, filling, and sealing of both 5 ML and 10 ML bottles within sterile manufacturing facilities. To qualify, the manufacturer must maintain FDA registration, ensure full cGMP compliance, and possess a unique NDC number. The annual delivery requirements consist of 392,107 bottles of the 5 ML size and 70,070 bottles of the 10 ML size. This subcontract opportunity falls under NAICS code 325412, with a response deadline of October 15, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Distribution ServicesThis subcontract for Pharmaceutical Distribution Services involves the supply and distribution of Glipizide Tablets to prime contractors supporting various government entities, including the VA, DoD, BOP, IHS, and FHCC. The scope of work encompasses comprehensive warehousing, inventory management, and FOB Destination shipping specifically tailored for Consolidated Mail Order Pharmacies and State Veterans Homes. To ensure product integrity, the operations utilize climate-controlled warehousing and specialized pharmaceutical transport vehicles for delivery to designated government destinations. Managed by Nac Pharmaceuticals under the Department of Veterans Affairs, the contract falls under NAICS code 424210, with a response deadline set for October 8, 2026.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling ServicesThis subcontract for Pharmaceutical Packaging and Labeling Services involves the packaging and labeling of Glipizide Tablets to support prime contractors delivering pharmaceutical supplies to the VA, DoD, BOP, IHS, and FHCC. The scope of work includes bottling, blister packing, and the application of labels that meet specific VA and DoD requirements using specialized pharmaceutical machinery. All operations must strictly adhere to FDA cGMP standards and the requirements outlined in Section 5 of the contract scope to ensure the tablets are ready for final shipment. This opportunity is issued by Nac Pharmaceuticals under the Department of Veterans Affairs, with a response deadline of October 8, 2026.

All Other Miscellaneous Manufacturing

POSTED

DEADLINE

Glipizide Tablet ManufacturingNac Pharmaceuticals is seeking a subcontractor for the manufacturing of Glipizide Tablets to support pharmaceutical supply contracts for the Department of Veterans Affairs, DoD, BOP, IHS, and FHCC. The scope of work encompasses the entire production process, including the chemical synthesis of the active pharmaceutical ingredient, tablet formulation, compression, and rigorous quality control testing. The selected provider must utilize pharmaceutical grade manufacturing equipment and maintain strict compliance with FDA cGMP standards. Key deliverables include the finished Glipizide Tablets and the provision of an 11-digit National Drug Code number. This subcontract opportunity falls under NAICS code 325412, with a response deadline of October 8, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--Glipizide Tablets

Solicitation # 36E79726R0031_1

The Department of Veterans Affairs National Acquisition Center is soliciting proposals for an unrestricted procurement of Glipizide Tablets in 5mg and 10mg strengths to support the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract consists of a one-year base period with four pre-priced one-year option periods. Award will be granted to the responsible offeror providing the lowest evaluated price among those meeting non-cost acceptability standards. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, with delivery terms set as FOB Destination. Technical requirements are stringent, requiring a unique 11-digit NDC number and specific unit-of-use packaging. Bottles must be cylindrical, have a minimum 120cc volume, a minimum 5.75 inch circumference, and utilize safety caps that are either convertible or deshellable; glass bottles are prohibited. Labeling must be exactly 5.25 by 2 inches and include GS1-128 or HIBCC compliant bar codes with a two-dimensional data matrix. Offerors must certify FDA approval via NDA, ANDA, or BLA and provide a Letter of Commitment if they are not the manufacturer. Proposals must be submitted electronically to the designated points of contact by the final deadline of October 8, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Logistics and Distribution to Prime Vendors

General Warehousing and Storage

POSTED

DEADLINE

Supply of Metoprolol Tartrate Active Pharmaceutical Ingredient (API)

Medicinal and Botanical Manufacturing

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS